approval
saveVABYSMO (FARICIMAB-SVOA) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 5
- approvaltrastuzumab emtansine: KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalFeb 2, 2022
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalJan 21, 2022
- approvalobinutuzumab: GAZYVA (OBINUTUZUMAB) — FDA approvalFeb 14, 2022
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalFeb 28, 2022
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalFeb 28, 2022
comments(0)
5-min edit window · permanent after that